BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

October 31, 2002

Study Completion Date

December 31, 2004

Conditions
Colorectal Cancer
Interventions
DRUG

BMS-247550

Trial Locations (15)

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

46601

Michiana Hematology/Oncology P.C., South Bend

49085

Lakeland Medical Center - St. Joseph, Saint Joseph

60068

Lutheran General Cancer Care Center, Park Ridge

60153

Loyola University Medical Center, Maywood

60201

Evanston Northwestern Health Care, Evanston

60426

Ingalls Memorial Hospital, Harvey

60525

LaGrange Memorial Hospital, LaGrange

60612

University of Illinois at Chicago, Chicago

60640

Louis A. Weiss Memorial Hospital, Chicago

61602

Oncology/Hematology Associates of Central Illinois, P.C., Peoria

62526

Decatur Memorial Hospital Cancer Care Institute, Decatur

62701

Central Illinois Hematology Oncology Center, Springfield

60637-1470

University of Chicago Cancer Research Center, Chicago

46885-5099

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Chicago

OTHER

NCT00022477 - BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter